» Articles » PMID: 30297303

Structure-activity Profiling of Alkaloid Natural Product Pharmacophores Against a Schistosoma Serotonin Receptor

Overview
Publisher Elsevier
Specialty Parasitology
Date 2018 Oct 10
PMID 30297303
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Serotonin (5-HT) is an important regulator of numerous aspects of flatworm biology, ranging from neuromuscular function to sexual maturation and egg laying. In the parasitic blood fluke Schistosoma mansoni, 5-HT targets several G-protein coupled receptors (GPCRs), one of which has been demonstrated to couple to cAMP and regulate parasite movement. This receptor, Sm.5HTR, has been successfully co-expressed in mammalian cells alongside a luminescent cAMP-biosensor, enabling pharmacological profiling for candidate anti-schistosomal drugs. Here, we have utilized this assay to perform structure-activity investigations of 143 compounds containing previously identified alkaloid natural product pharmacophores (tryptamines, aporphines and protoberberines) shown to regulate Sm.5HTR. These experiments mapped regions of the tryptamine pharmacophore amenable and intolerant to substitution, highlighting differences relative to orthologous mammalian 5-HT receptors. Potent Sm.5HTR antagonists were identified, and the efficacy of these compounds were evaluated against live adult parasites cultured ex vivo. Such structure-activity profiling, characterizing the effect of various modifications to these core ring systems on Sm.5HTR responses, provides greater understanding of pharmacophores selective for this target to aid future drug development efforts.

Citing Articles

Machine learning field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification.

Floresta G, Abbate V RSC Adv. 2022; 11(24):14587-14595.

PMID: 35424006 PMC: 8697832. DOI: 10.1039/d1ra01335a.


Serotonin Signalling in Flatworms: An Immunocytochemical Localisation of 5-HT Type of Serotonin Receptors in and .

Kreshchenko N, Terenina N, Ermakov A Biomolecules. 2021; 11(8).

PMID: 34439878 PMC: 8394519. DOI: 10.3390/biom11081212.


Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Moreira-Filho J, Silva A, Dantas R, Gomes B, Souza Neto L, Brandao-Neto J Front Immunol. 2021; 12:642383.

PMID: 34135888 PMC: 8203334. DOI: 10.3389/fimmu.2021.642383.


Emerging biosensors in detection of natural products.

Piroozmand F, Mohammadipanah F, Faridbod F Synth Syst Biotechnol. 2020; 5(4):293-303.

PMID: 32954023 PMC: 7484522. DOI: 10.1016/j.synbio.2020.08.002.


Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni.

Duguet T, Glebov A, Hussain A, Kulkarni S, Mochalkin I, Geary T Int J Parasitol Drugs Drug Resist. 2020; 13:73-88.

PMID: 32531750 PMC: 7284125. DOI: 10.1016/j.ijpddr.2020.05.002.


References
1.
Tomosky T, Bennett J, Bueding E . Tryptaminergic and dopaminergic responses of Schistosoma mansoni. J Pharmacol Exp Ther. 1974; 190(2):260-71. View

2.
Cabedo N, Berenguer I, Figadere B, Cortes D . An overview on benzylisoquinoline derivatives with dopaminergic and serotonergic activities. Curr Med Chem. 2009; 16(19):2441-67. DOI: 10.2174/092986709788682100. View

3.
Zamanian M, Kimber M, McVeigh P, Carlson S, Maule A, Day T . The repertoire of G protein-coupled receptors in the human parasite Schistosoma mansoni and the model organism Schmidtea mediterranea. BMC Genomics. 2011; 12:596. PMC: 3261222. DOI: 10.1186/1471-2164-12-596. View

4.
Patocka N, Ribeiro P . Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis. Mol Biochem Parasitol. 2007; 154(2):125-33. DOI: 10.1016/j.molbiopara.2007.03.010. View

5.
Chan J, Acharya S, Day T, Marchant J . Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist. Int J Parasitol Drugs Drug Resist. 2016; 6(3):364-370. PMC: 5196489. DOI: 10.1016/j.ijpddr.2016.06.001. View